Acne Vulgaris

36 competing products in clinical development for Acne Vulgaris.

Pipeline by Phase

Phase 121
Phase 23
Phase 36
Approved6

All Products (36)

ProductCompanyStageStatusHype
Winlevi (Clascoterone) cream 1%Sun PharmaceuticalApprovedActive
47
Winlevi (clascoterone) 1% & Duac gelSun PharmaceuticalApprovedCompleted
43
Winlevi (clascoterone) 1% creamSun PharmaceuticalApprovedCompleted
43
Winlevi (clascoterone) 1% creamSun PharmaceuticalApprovedCompleted
43
Winlevi (clascoterone) 1% creamSun PharmaceuticalApprovedCompleted
43
Winlevi (clascoterone) 1% & Adapalene 0.3% gelSun PharmaceuticalApprovedCompleted
43
Olumacostat Glasaretil Gel, 5.0%Eli LillyPhase 3Completed
40
Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd) + ACZONE® (dapsone) gel, 7.5% (Allergan, INC.)Torrent PharmaceuticalsPhase 3Completed
40
Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel + DUAC® Gel + PlaceboZydus LifesciencesPhase 3Completed
40
Olumacostat Glasaretil Gel, 5.0%Eli LillyPhase 3Completed
40
DFD-03Dr. Reddy's LaboratoriesPhase 3Completed
37
DFD-03 (0.1% tazarotene) Lotion + DFD-03 (0% tazarotene) Lotion (Placebo)Dr. Reddy's LaboratoriesPhase 3Completed
37
ADPS topical product + Placebo ControlSun PharmaceuticalPhase 2Completed
35
Tazarotene Lotion, 0.1% + Tazarotene Cream, 0.1%Dr. Reddy's LaboratoriesPhase 2Completed
32
DFD-03 Lotion, 0.1% + Tazorac Cream, 0.1% + DFD-03 Vehicle Lotion 0% + Tazorac Vehicle Cream 0%Dr. Reddy's LaboratoriesPhase 2Completed
32
Trifarotene Cream 0.005% + AKLIEF® Cream (Trifarotene 0.005%) US REFERENCE LISTED DRUG + AKLIEF® Cream (Trifarotene 50 mcg/g) CANADIAN REFERENCE PRODUCT + PlaceboSun PharmaceuticalPhase 1Completed
29
Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo ControlSun PharmaceuticalPhase 1Completed
29
Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% + Acanya® Gel, 1.2%/2.5% + Vehicle of test productSun PharmaceuticalPhase 1Completed
29
Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + Duac® Topical Gel + Placebo Topical GelSun PharmaceuticalPhase 1Completed
29
Adapalene Gel 0.1% + Placebo Control + Differin® Gel (Adapalene 0.1%, Galderma)Sun PharmaceuticalPhase 1Completed
29
Trifarotene Cream 0.005% + Placebo + AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories)Sun PharmaceuticalPhase 1Completed
29
Adapalene/BP gel, 0.3%/2.5% + EPIDUO® FORTE + PlaceboSun PharmaceuticalPhase 1Completed
29
Adapalene Gel 0.3% + Differin® + PlaceboSun PharmaceuticalPhase 1Completed
29
CLPG Topical Gel 1% + Clindamycin + PlaceboSun PharmaceuticalPhase 1Completed
29
Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% + Epiduo® Gel + PlaceboSun PharmaceuticalPhase 1Completed
29
Test. + Aczone Gel 5% + PlaceboSun PharmaceuticalPhase 1Completed
29
Clindamycin and Benzoyl Peroxide Gel 1%5% + BenzaClin® Topical Gel + PlaceboSun PharmaceuticalPhase 1Completed
29
Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% + Onexton™ Gel + PlaceboSun PharmaceuticalPhase 1Completed
29
Clindamycin Phosphate + Clindamycin Phosphate RLD + PlacebosSun PharmaceuticalPhase 1Completed
29
Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% + CABTREO Topical Gel + Placebo ControlSun PharmaceuticalPhase 1Completed
29
Tretinoin cream, 0.05% + RETIN-A® (tretinoin) cream, 0.05% + Vehicle of the test productSun PharmaceuticalPhase 1Completed
29
DPSG 7.5% + Aczone + PlaceboSun PharmaceuticalPhase 1Completed
29
Tretinoin Gel Microsphere, 0.04% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.04% + Placebo ControlSun PharmaceuticalPhase 1Completed
29
Tretinoin cream 0.1% + RETIN-A® Cream + Vehicle of the test productSun PharmaceuticalPhase 1Completed
29
Tazarotene Cream 0.1% + Tazorac® + PlaceboSun PharmaceuticalPhase 1Completed
29
Tretinoin Cream 0.025%Sun PharmaceuticalPhase 1Completed
29